217 related articles for article (PubMed ID: 32622542)
1. Review of Relative effectiveness assessments (REAs) of pharmaceuticals at the European network for health technology assessment (EUnetHTA): A first step towards a consolidated European perspective on comparative effectiveness & safety?
Chassagnol F; Marcelli G; Wagle J; Giuliani G; Traub D; Schaub V; Ruof J
Health Policy; 2020 Sep; 124(9):943-951. PubMed ID: 32622542
[TBL] [Abstract][Full Text] [Related]
2. Leveraging EUnetHTA's conceptual framework to compare HTA decision drivers in France, Italy, and Germany from a manufacturer's point of view.
Giuliani G; Chassagnol F; Traub D; Gyldmark M; Hebborn A; Ducournau P; Ruof J
Health Econ Rev; 2018 Sep; 8(1):24. PubMed ID: 30242522
[TBL] [Abstract][Full Text] [Related]
3. Health technology assessment of medical devices: What is different? An overview of three European projects.
Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
[TBL] [Abstract][Full Text] [Related]
4. EUnetHTA relative effectiveness assessments: efforts to increase usability, transparency and inclusiveness.
Willemsen A; Ettinger S; Helmink C; Erdos J; Hviding K; Ormstad SS
Int J Technol Assess Health Care; 2022 May; 38(1):e41. PubMed ID: 35615861
[TBL] [Abstract][Full Text] [Related]
5. The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs.
Vreman RA; Bloem LT; van Oirschot S; Hoekman J; van der Elst ME; Leufkens HG; Klungel OH; Goettsch WG; Mantel-Teeuwisse AK
Int J Health Policy Manag; 2022 May; 11(5):642-650. PubMed ID: 33131224
[TBL] [Abstract][Full Text] [Related]
6. Stakeholder perspectives on cooperation in the clinical and nonclinical health technology assessment domains.
Zimmermann G; Michelmore S; Hiligsmann M
Int J Technol Assess Health Care; 2023 May; 39(1):e29. PubMed ID: 37212049
[TBL] [Abstract][Full Text] [Related]
7. [HTA goes Europe: European collaboration on joint assessment and methodological issues becomes reality].
Nachtnebel A; Mayer J; Erdös J; Lampe K; Kleijnen S; Schnell-Inderst P; Wild C
Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):291-9. PubMed ID: 26354129
[TBL] [Abstract][Full Text] [Related]
8. European network for Health Technology Assessment Joint Action (EUnetHTA JA): a process evaluation performed by questionnaires and documentary analysis.
Woodford Guegan E; Cook A
Health Technol Assess; 2014 Jun; 18(37):1-296. PubMed ID: 24913263
[TBL] [Abstract][Full Text] [Related]
9. Relative effectiveness assessments of oncology medicines for pricing and reimbursement decisions in European countries.
Kleijnen S; Lipska I; Leonardo Alves T; Meijboom K; Elsada A; Vervölgyi V; d'Andon A; Timoney A; Leufkens HG; De Boer A; Goettsch WG
Ann Oncol; 2016 Sep; 27(9):1768-75. PubMed ID: 27329251
[TBL] [Abstract][Full Text] [Related]
10. Developing a quality management system for the European Network for Health Technology Assessment (EUnetHTA): toward European HTA collaboration.
Luhnen M; Ormstad SS; Willemsen A; Schreuder-Morel C; Helmink C; Ettinger S; Erdos J; Fathollah-Nejad R; Rehrmann M; Hviding K; Rüther A; Chalon PX
Int J Technol Assess Health Care; 2021 Apr; 37(1):e59. PubMed ID: 33902782
[TBL] [Abstract][Full Text] [Related]
11. Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies.
Makady A; van Veelen A; Jonsson P; Moseley O; D'Andon A; de Boer A; Hillege H; Klungel O; Goettsch W
Pharmacoeconomics; 2018 Mar; 36(3):359-368. PubMed ID: 29214389
[TBL] [Abstract][Full Text] [Related]
12. [Methodological guideline for the efficacy and safety assessment of new pharmaceuticals: implementation of EUnetHTA's recommendations].
Ubago Pérez R; Castillo Muñoz MA; Banqueri MG; García Estepa R; Alfaro Lara ER; Vega Coca MD; Beltrán Calvo C; Molina López T
Gac Sanit; 2017; 31(4):336-341. PubMed ID: 28062129
[TBL] [Abstract][Full Text] [Related]
13. Building a model of health technology assessment cooperation: lessons learned from EUnetHTA joint action 3.
Garrett Z; Imaz-Iglesia I; Willemsen A
Int J Technol Assess Health Care; 2022 Jan; 38(1):e14. PubMed ID: 35086599
[TBL] [Abstract][Full Text] [Related]
14. Addressing uncertainty in relative effectiveness assessments by HTA organizations.
Vreman RA; Strigkos G; Leufkens HGM; Schünemann HJ; Mantel-Teeuwisse AK; Goettsch WG
Int J Technol Assess Health Care; 2022 Jan; 38(1):e17. PubMed ID: 35094740
[TBL] [Abstract][Full Text] [Related]
15. Early Dialogues for Pharmaceutical Products in European Network for Health Technology Assessment Joint Action 3: What Was Done and Where to Go in the Future.
Galbraith M; Guilhaume C; Bélorgey C
Int J Technol Assess Health Care; 2022 Mar; 38(1):e30. PubMed ID: 35321768
[TBL] [Abstract][Full Text] [Related]
16. Differences in Evidentiary Requirements Between European Medicines Agency and European Health Technology Assessment of Oncology Drugs-Can Alignment Be Enhanced?
Wolters S; Jansman FGA; Postma MJ
Value Health; 2022 Dec; 25(12):1958-1966. PubMed ID: 35752535
[TBL] [Abstract][Full Text] [Related]
17. Success factors for international HTA projects: evaluating EUnetHTA Joint Action as an exemplar.
Guegan EW; Cook A
Int J Technol Assess Health Care; 2014 Nov; 30(5):544-51. PubMed ID: 25747565
[TBL] [Abstract][Full Text] [Related]
18. Information specialist collaboration in Europe: collaborative methods, processes, and infrastructure through EUnetHTA.
Waffenschmidt S; van Amsterdam-Lunze M; Gomez RI; Rehrmann M; Harboe I; Hausner E
Int J Technol Assess Health Care; 2020 Oct; 37():e20. PubMed ID: 33081862
[TBL] [Abstract][Full Text] [Related]
19. [European Collaboration in Medical Device Assessment: One Step Towards Cross-Border Health Care].
Mayer J; Ettinger S; Nachtnebel A
Gesundheitswesen; 2018 Mar; 80(3):210-216. PubMed ID: 28628932
[TBL] [Abstract][Full Text] [Related]
20. Endpoints for relative effectiveness assessment (REA) of pharmaceuticals.
Pavlovic M; Teljeur C; Wieseler B; Klemp M; Cleemput I; Neyt M
Int J Technol Assess Health Care; 2014 Nov; 30(5):508-13. PubMed ID: 25747560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
